Lifecore Biomedical
LFCR
LFCR
86 hedge funds and large institutions have $221M invested in Lifecore Biomedical in 2025 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 34 increasing their positions, 18 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
6% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 17
1% less funds holding
Funds holding: 87 → 86 (-1)
36% less call options, than puts
Call options by funds: $76K | Put options by funds: $118K
Holders
86
Holding in Top 10
6
Calls
$76K
Puts
$118K
Top Buyers
| 1 | +$4.95M | |
| 2 | +$2.56M | |
| 3 | +$920K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$900K |
| 5 |
BlackRock
New York
|
+$741K |
Top Sellers
| 1 | -$10.1M | |
| 2 | -$509K | |
| 3 | -$321K | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$254K |
| 5 |
Boston Partners
Boston,
Massachusetts
|
-$241K |